Dr. James Huang

Dr. James Huang, MD, is a highly respected thoracic surgeon and a leading authority in the surgical treatment of lung, esophageal, and mediastinal cancers. He serves as an Attending Surgeon at Memorial Sloan Kettering Cancer Center and is a member of the Department of Surgery's Thoracic Service, where he plays an integral role in delivering world-class cancer care. Dr. Huang earned his medical degree from the Columbia University College of Physicians and Surgeons and completed both his general surgery residency and thoracic surgery fellowship at NewYork-Presbyterian Hospital/Columbia University Medical Center. Board-certified in thoracic surgery, he is renowned for his expertise in complex thoracic procedures, including minimally invasive and robotic-assisted approaches.

Dr. Huang’s clinical interests center on early-stage non-small cell lung cancer, esophageal cancer, mediastinal tumors, and the surgical management of mesothelioma. He is known for his precision in performing lung-sparing operations and lymph node dissections, advancing techniques that emphasize patient safety and long-term outcomes. His research contributions include extensive work on prognostic biomarkers, surgical outcomes, and the multidisciplinary management of thoracic malignancies. He has authored numerous peer-reviewed articles and book chapters and remains actively involved in research that bridges surgical practice with translational science.

In addition to his clinical and academic accomplishments, Dr. Huang is deeply committed to mentorship and education. He actively trains surgical residents and fellows at MSKCC, fostering a new generation of thoracic surgeons through rigorous education and compassionate care models. He is a Fellow of the American College of Surgeons and an engaged member of professional societies such as the Society of Thoracic Surgeons and the International Association for the Study of Lung Cancer. With a steadfast commitment to innovation, patient-centered care, and collaborative research, Dr. Huang continues to shape the future of thoracic oncology surgery.